Literature DB >> 24551632

Causality, severity and preventability assessment of adverse cutaneous drug reaction: a prospective observational study in a tertiary care hospital.

Padmavathi S1, Manimekalai K2, Ambujam S3.   

Abstract

INTRODUCTION: The number of subjects involved in a clinical trial are limited, whose findings cannot be extrapolated to the entire population.Due to the emergence of newer molecules the pattern of Adverse Cutaneous Drug Reaction(ACDR) also changes frequently. The need for this study is for early diagnosis, to reduce the morbidity and mortality due to ACDR and to ensure safety of the patients.
MATERIAL AND METHODS: Forty one subjects with the diagnosis of ACDR were included in the study for a period of 12 months(Jan 2009- Dec 2009). The informations such as patient demographic details, drug history, associated comorbid conditions and pattern of the skin reaction were noted. Assessment was done for causality, severity and preventability using separate valid scales.
RESULTS: The most common ACDR was fixed drug eruption (43.9%) and the most common causative drug for the same was surprisingly found to be paracetamol. Antimicrobials were the most common causative drug group and two significant associated risk factors were multiple drug intake and history of allergy. Among the total reactions 78% were of probable category and 59% were of moderate level severity reaction. Out of which 12% of the cases were definitely preventable.

Entities:  

Keywords:  Drug alert card; Fixed drug eruption; Polypharmacy

Year:  2013        PMID: 24551632      PMCID: PMC3919327          DOI: 10.7860/JCDR/2013/7430.3753

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Preventability and severity assessment in reporting adverse drug reactions.

Authors:  S C Hartwig; J Siegel; P J Schneider
Journal:  Am J Hosp Pharm       Date:  1992-09

2.  Cutaneous adverse reactions in in-patients in a tertiary care hospital.

Authors:  R Jhaj; R Uppal; S Malhotra; V K Bhargava
Journal:  Indian J Dermatol Venereol Leprol       Date:  1999 Jan-Feb       Impact factor: 2.545

3.  Cutaneous drug reactions.

Authors:  B Tank; R Poria; R C Rawal; F E Bilimoria
Journal:  Indian J Dermatol Venereol Leprol       Date:  1996 Sep-Oct       Impact factor: 2.545

4.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

5.  Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India.

Authors:  David Pudukadan; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Jan-Feb       Impact factor: 2.545

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Pharmacovigilance inspections.

Authors:  Patricia Fitzgerald
Journal:  Indian J Pharmacol       Date:  2008-02       Impact factor: 1.200

Review 8.  Cutaneous reactions to drugs in children.

Authors:  Alissa R Segal; Kevin M Doherty; John Leggott; Barrett Zlotoff
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

9.  Adverse Drug Reactions (ADR) in the inPatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR.

Authors:  A P Gor; S V Desai
Journal:  Indian J Pharmacol       Date:  2008-01       Impact factor: 1.200

10.  Adverse cutaneous drug reaction.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

View more
  10 in total

1.  Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005-2014).

Authors:  Hossein Kavoussi; Mansour Rezaei; Katayoun Derakhshandeh; Alireza Moradi; Ali Ebrahimi; Harif Rashidian; Reza Kavoussi
Journal:  Dermatol Res Pract       Date:  2015-12-10

2.  Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.

Authors:  Sadia Iftikhar; Muhammad Rehan Sarwar; Anum Saqib; Muhammad Sarfraz
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

3.  Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan.

Authors:  Anum Saqib; Muhammad Rehan Sarwar; Muhammad Sarfraz; Sadia Iftikhar
Journal:  BMC Pharmacol Toxicol       Date:  2018-06-25       Impact factor: 2.483

4.  Analysis of Cutaneous Adverse Drug Reactions Reported at the Regional ADR Monitoring Center.

Authors:  Anal Modi; Mira Desai; Samidh Shah; Bela Shah
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

5.  Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.

Authors:  Ranjana Beniwal; Lalit Kumar Gupta; Ashok Kumar Khare; Asit Mittal; Sharad Mehta; Manisha Balai
Journal:  Indian Dermatol Online J       Date:  2019 Jan-Feb

6.  Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis.

Authors:  Yogendra Keche; Nitin Gaikwad; Suryaprakash Dhaneria
Journal:  J Family Med Prim Care       Date:  2021-07-30

7.  Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India.

Authors:  Raakhi K Tripathi; Snehalata Gajbhiye; Sharmila Jalgaonkar; Nishtha Khatri; Mohsin Sayyed; Shubhangi Parkar
Journal:  Cureus       Date:  2022-03-22

8.  Rifabutin induced hypopyon uveitis mimicking endophthalmitis as a manifestation of IRU in patients with HIV.

Authors:  Nivedita Nair; S Sudharshan; Nikunj Ashokbhai Koladiya; Jyotirmay Biswas
Journal:  Indian J Pharmacol       Date:  2022 Jan-Feb       Impact factor: 1.200

9.  Bullous Fixed Drug Eruption Probably Induced by Paracetamol.

Authors:  Manoj Kumar Agarwala; Sramana Mukhopadhyay; M Raja Sekhar; Cv Dincy Peter
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

10.  Cefotaxime induced generalized bullous fixed drug eruption - A case report.

Authors:  R Manikandan; A Porselvi; G C Keerthana; K Vaishnavi; S Girija; Murali Narasimhan; T M Vijayakumar
Journal:  Toxicol Rep       Date:  2018-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.